← Back to headlines
Revolution Medicines Prices $2B in Stock and Notes Offerings
Revolution Medicines has priced $2 billion in concurrent stock and notes offerings.
15 Apr, 10:15 — 15 Apr, 10:15
Sources
Showing 1 of 1 sources
Revolution Medicines has priced $2 billion in concurrent stock and notes offerings.